earnings
FA
NASDAQ · FATE
Fate Therapeutics, Inc.
Healthcare · Biotechnology
$1.28
Down-$0.14 (-10.94%)
Updated Nov 17, 2026, 1:02 AM
SID Score
4.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 128M
- P/E ratio
- -0.85
- Dividend yield
- 0.00%
- 52-week range
- $0.95 – $3.23
- Volume
- 1.81M
- Avg. volume
- 2.11M
Price performance · FATE
FATE price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Nov 13, 2026
FATE closed at $1.28 after 20 trading sessions, down 31.18% for the selected period.
- Last close
- $1.28
- Period change
- -31.18%
- Period low
- $1.28
- Period high
- $2.17
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | $1.32 | $1.33 | $1.21 | $1.28 | 1.81M |
| Nov 12, 2026 | $1.58 | $1.585 | $1.2501 | $1.34 | 3.69M |
| Nov 11, 2026 | $1.78 | $1.795 | $1.60 | $1.605 | 2.65M |
| Nov 10, 2026 | $1.90 | $1.9587 | $1.70 | $1.77 | 1.77M |
| Nov 9, 2026 | $1.87 | $2.00 | $1.85 | $1.94 | 2.21M |
| Nov 6, 2026 | $1.85 | $1.95 | $1.81 | $1.835 | 1.86M |
| Nov 5, 2026 | $1.97 | $2.0299 | $1.82 | $1.85 | 2.81M |
| Nov 4, 2026 | $2.05 | $2.10 | $2.025 | $2.09 | 724K |
| Nov 3, 2026 | $2.02 | $2.12 | $2.005 | $2.04 | 876.21K |
| Nov 2, 2026 | $2.09 | $2.15 | $1.98 | $2.01 | 1.27M |
| Oct 30, 2026 | $2.13 | $2.165 | $2.01 | $2.08 | 1.06M |
| Oct 29, 2026 | $2.17 | $2.23 | $2.12 | $2.17 | 804.29K |
| Oct 28, 2026 | $2.04 | $2.18 | $2.035 | $2.17 | 1.11M |
| Oct 27, 2026 | $2.05 | $2.09 | $2.03 | $2.07 | 923.56K |
| Oct 26, 2026 | $2.10 | $2.14 | $2.04 | $2.055 | 1.46M |
| Oct 23, 2026 | $2.08 | $2.135 | $2.015 | $2.11 | 1.11M |
| Oct 22, 2026 | $2.07 | $2.11 | $2.035 | $2.09 | 867.18K |
| Oct 21, 2026 | $2.06 | $2.14 | $2.045 | $2.07 | 1.22M |
| Oct 20, 2026 | $1.86 | $2.145 | $1.84 | $2.06 | 1.77M |
| Oct 19, 2026 | $1.79 | $1.90 | $1.75 | $1.86 | 1.68M |
Latest FATE news
The latest Smart Investors Daily articles mentioning FATE.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…

